MADRIGAL PHARMACEUTICALS, INC. 4

Rebecca Taub received an equity compensation package consisting of 454 RSU shares of Madrigal Pharmaceuticals common stock and stock options for 766 shares at $499.86 per share.

On June 17, 2026, Rebecca Taub of Madrigal Pharmaceuticals, Inc. received two equity awards as part of her compensation: 454 shares of common stock in the form of restricted stock units that will vest on the earlier of June 17, 2027 or the company’s 2027 annual shareholder meeting, and a stock option to purchase 766 shares of common stock at an exercise price of $499.86 per share, vesting on the same schedule. Following these grants, she directly owns 452,667 shares of Madrigal common stock, and she also has indirect beneficial ownership of 655,540 shares held by SQN LLC, where she and her spouse are managing members, though she disclaims beneficial ownership beyond her pecuniary interest. Assuming the option exercise price approximates the current market price, her direct equity stake is valued at roughly $226 million after the awards.

Filing Facts

CIK

1157601

Ticker

MDGL

Form

4

Source Type

sec

Accession

0001628280-26-044346

Alert Tier

5